Testosterone enantate is a long-acting injectable testosterone ester used in the treatment of hypogonadism in adult males — a condition in which the body produces insufficient testosterone. As a testosterone ester in an oily vehicle, it is slowly released from the intramuscular injection site into the bloodstream over one to three weeks, providing sustained testosterone replacement between doses. Testosterone enantate is one of the most widely used injectable TRT formulations and is prescribed as a prescription-only medicine under specialist supervision at PrimeLife.
How It Works
Following intramuscular injection, testosterone enantate forms a depot at the injection site from which it is gradually released into the circulation. The ester bond is then cleaved by serum esterases, releasing free testosterone that acts on androgen receptors throughout the body. Testosterone levels rise following the injection, reaching a peak within the first few days, and then decline gradually until the next dose. The dosing interval is typically every two to three weeks, though this may be adjusted based on serum testosterone monitoring and individual clinical response. Regular testosterone level monitoring is essential to ensure levels remain within the therapeutic range throughout treatment.
Why Choose Testosterone Enantate for TRT
Testosterone enantate is a well-established formulation with decades of clinical use and a well-documented safety and efficacy profile in the management of hypogonadism. The longer dosing interval compared to some other injectable preparations may be preferable for patients who find frequent administration inconvenient. For patients comfortable with self-administration following clinician training, testosterone enantate offers effective and cost-efficient TRT without daily gel application or concerns about transfer to household members.
As with all TRT at PrimeLife, dosing and injection intervals are individualised based on regular blood monitoring to ensure testosterone levels remain within the physiological target range. This personalised approach ensures that treatment is optimised for each individual patient rather than applying a standard protocol regardless of the clinical response.
Important Note
Testosterone enantate is a prescription-only medicine for adult males only. It must not be used in women or children. Regular blood monitoring including serum testosterone, haematocrit, and PSA is required throughout treatment. Common side effects include injection site reactions, acne, increased body hair, mood changes, and elevated haematocrit. Polycythaemia is a recognised risk and requires monitoring. This medication is contraindicated in patients with known or suspected prostate or breast cancer and serious cardiovascular conditions. It must only be used as directed by a qualified prescriber as part of a supervised TRT programme with regular clinical review at PrimeLife.
